Canadian Market Down Marginally In Cautious Trade

RTTNews | 33 dias atrás
Canadian Market Down Marginally In Cautious Trade

(RTTNews) - Canadian stocks are turning in a mixed performance Thursday afternoon with investors largely staying cautious and refraining from making significant moves.

Consumer staples stocks are weak, while materials shares are finding good support. Stocks from the rest of the sectors are mostly subdued.

The benchmark S&P/TSX Composite Index was down 29.22 points or 0.12% at 21,626.83 a little while ago. The index had climbed to 21,799.35 around late morning.

Canopy Growth Corporation (WEED.TO) is soaring nearly 22%. First Quantum Minerals (FM.TO) is up with a hefty gain of 10%.

ATS Corporation (ATS.TO) is up 6.3%. Rogers Communications (RCI.A.TO) is climbing 3.6%. Morguard Corporation (MRC.TO), Teck Resources (TECK.A.TO), Agnico Eagle Mines (AEM.TO) and Canadian Tire Corporation (CTC.A.TO) are gaining 1 to 2.6%.

Lithium Americas Corp (LAC.TO) is plunging 28%. The company said on Wednesday that it would raise US$275 million by selling 55 million common shares at US$5 apiece in an underwritten public offering expected to close on April 22. The company plans to use the proceeds to advance the construction and development of its Thacker Pass lithium project in Humboldt County, Nevada.

Aritzia Inc (ATZ.TO) is down 3.7%. BRP Inc (DOO.TO), Celestica Inc (CLS.TO), WSP Global (WSP.TO), Thomson Reuters (TRI.TO), Imperial Oil (IMO.TO), Loblaw Companies (L.TO), Dollarama (DOL.TO), FirstService Corporation (FSV.TO) and Colliers International (CIGI.TO) are down 1 to 2.6%.

read more
Bay Street Likely To Open Lower

Bay Street Likely To Open Lower

Canadian shares are likely to open on a slightly negative note Wednesday morning as energy and materials sectors may find the going somewhat tough due to weak commodity prices.
RTTNews | 4 h 23 min atrás
Biogen To Buy Human Immunology Biosciences In Deal Valued At Up To $1.8 Bln

Biogen To Buy Human Immunology Biosciences In Deal Valued At Up To $1.8 Bln

Biogen Inc. (BIIB) and privately-held biotechnology company Human Immunology Biosciences or HI-Bio, announced Wednesday the companies have entered into a definitive agreement under which Biogen has agreed to acquire HI-Bio for $1.15 billion upfront and up to $650 million in potential milestone payments.
RTTNews | 4 h 26 min atrás
UK Inflation Slows Less Than Expected To 2.3%

UK Inflation Slows Less Than Expected To 2.3%

UK consumer prices rose more than expected in April due to the stickiness of services inflation, which would possibly delay the timing of the first interest rate cut. Consumer prices rose 2.3 percent on a yearly basis in April, slower than the 3.2 percent increase in March, the Office for National Statistics reported Wednesday.
RTTNews | 4 h 36 min atrás
Target Q1 Profit Misses Estimates, Backs FY24 View; Stock Down

Target Q1 Profit Misses Estimates, Backs FY24 View; Stock Down

Target Corp. shares were losing more than 8 percent in pre-market activity on the NYSE after the general merchandise retailer reported weak profit, sales and comparable sales in its first quarter. Earnings per share missed the Street estimates. Further, the company issued second-quarter outlook and maintained fiscal 2024 forecast.
RTTNews | 5 h 28 min atrás
RBNZ Holds Key Interest Rate; Delays Rate Cut Plan

RBNZ Holds Key Interest Rate; Delays Rate Cut Plan

New Zealand's central bank maintained its benchmark rate for the seventh consecutive session and signaled a delay in rate cuts as services inflation is receding slowly. The Monetary Policy Committee of the Reserve Bank of New Zealand, led by Governor Adrian Orr, decided to hold the Official Cash Rate at 5.50 percent.
RTTNews | 5 h 52 min atrás